Physician profile

Yuda Liu

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Dalton, GA

NPI 1629311451

$1,253.45

in general payments reported to CMS, 2019-2025

7 companies · $13.79 in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$87.56

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $999.59 2019
Medtronic Vascular, INC. $101.63 2020
Medtronic, INC. $46.32 2021-2024 Venaseal
Smith+Nephew, INC. $32.46 2022
Cgg Medical INC $32.02 2024
Artivion, INC. $27.64 2023 Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder
Stryker Corporation $13.79 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Yuda Liu

$1,253.45

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation

https://glasscript.com/doctor/1262952/yuda-liu

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.